The Myelodysplastic Syndromes Foundation and SparkCures Join Forces to Enhance Clinical Trial Navigation for Myelodysplastic Syndromes Patients

Pittsburgh, PA, September 12, 2023 – The Myelodysplastic Syndromes Foundation (MDS Foundation), a global non-profit advocacy organization dedicated to supporting patients and healthcare providers in the field of myelodysplastic syndromes […]

Molecular International Prognostic Scoring System Developed for Myelodysplastic Syndromes

Efficient, Accurate Risk Stratification Will Transform Patient Care JUNE 12, 2022 YARDVILLE, N.J., June 12, 2022 [Newswire]—Today, the MDS Foundation announced the development of a new prognostic scoring system, the […]

Molecular International Prognostic Scoring System Developed For Myelodysplastic Syndromes – Read More

Improving Understanding of MDS Using an Animated Patient’s Guide to Benefit Patient Health Outcomes – Read More

Large International Study Pinpoints Impact of TP53 Mutations on Blood Cancer Severity

Having two mutated copies of the TP53 gene – as opposed to a single mutated copy – is associated with worse outcomes in myelodysplastic syndrome and acute myeloid leukemia. YARDVILLE, […]